首页> 外文期刊>Journal of Basic and Clinical Pharmacy >Evaluation of Anticancer Drug Utilization and Monitoring of Adverse Drug Reaction in the Indoor Patients Receiving Cancer Chemotherapy in a Tertiary Care Hospital in New Delhi
【24h】

Evaluation of Anticancer Drug Utilization and Monitoring of Adverse Drug Reaction in the Indoor Patients Receiving Cancer Chemotherapy in a Tertiary Care Hospital in New Delhi

机译:在新德里三级护理医院评估接受室内化疗的室内患者的抗癌药物利用和药物不良反应监测

获取原文
           

摘要

The main aim of drug utilization evaluation (DUE) is to promote the rational use of drugs in populations. The present study was designed to evaluate drug utilization pattern of anticancer drugs and to monitor the adverse drug reactions (ADR’s) in cancer patients receiving chemotherapy. Newly diagnosed patients of carcinoma which required treatment with chemotherapy, patients of both sex, and age18 years were included in the study. Cisplatin (20% patients) is the most commonly prescribed anti-cancer drug in this study followed by 5-Fluorouracil (16% patients). Average number of drugs per prescription was 9.18 and percentage of drugs prescribed from Essential Drugs List (EDL) was 93.5%. ADR’s were observed in 93% of the study patients. The most commonly implicated group of anticancer agents in ADR’s, was platinum analog (32%) followed by antimetabolites (22%) and taxanes (20%). Antimicrobial agents use was observed to be restricted and judicious.
机译:药物利用评价(DUE)的主要目的是促进人群中药物的合理使用。本研究旨在评估抗癌药的药物利用模式并监测接受化疗的癌症患者的药物不良反应(ADR)。本研究纳入了新诊断的需要化疗的癌症患者,性别和年龄大于18岁的患者。顺铂(20%的患者)是该研究中最常用的抗癌药物,其次是5-氟尿嘧啶(16%的患者)。每个处方药的平均药物数量为9.18,基本药物清单(EDL)处方的药物百分比为93.5%。在93%的研究患者中观察到了ADR。在ADR中,最常见的抗癌药是铂类似物(32%),其次是抗代谢物(22%)和紫杉烷类(20%)。观察到抗菌剂的使用受到限制并且是明智的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号